canrenone has been researched along with natriuretic peptide, brain in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boccanelli, A; Cacciatore, G; Clemenza, F; de Simone, G; Di Lenarda, A; Gavazzi, A; Latini, R; Lucci, D; Maggioni, AP; Masson, S; Mureddu, GF; Porcu, M; Vanasia, M | 1 |
Boccanelli, A; Cacciatore, G; Chinali, M; de Simone, G; Latini, R; Lucci, D; Maggioni, AP; Masson, S; Mureddu, GF; Vanasia, M | 1 |
Bianchi, L; Bonaventura, A; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Romano, D | 1 |
Bianchi, L; D'Angelo, A; Derosa, G; Maffioli, P; Romano, D | 1 |
4 trial(s) available for canrenone and natriuretic peptide, brain
Article | Year |
---|---|
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Canrenone; Chronic Disease; Creatinine; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Treatment Outcome; Ultrasonography; Ventricular Remodeling; Young Adult | 2009 |
Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: the AREA-in-CHF study.
Topics: Aged; Canrenone; Double-Blind Method; Female; Heart Failure, Systolic; Heart Ventricles; Humans; Male; Metabolic Syndrome; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Peptide Fragments; Placebos; Procollagen | 2011 |
Effects of canrenone in patients with metabolic syndrome.
Topics: Aged; Aldosterone; Blood Glucose; Blood Pressure; C-Reactive Protein; Canrenone; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Tumor Necrosis Factor-alpha | 2013 |
The effects of canrenone on inflammatory markers in patients with metabolic syndrome.
Topics: Aged; Aldosterone; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Canrenone; Creatine; Double-Blind Method; Fasting; Female; Humans; Inflammation; Lipids; Lipoproteins; Male; Metabolic Syndrome; Metalloproteases; Middle Aged; Natriuretic Peptide, Brain; Peroxidase; Potassium; White People | 2015 |